Literature DB >> 18804346

Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Todd L Edwards1, Xu Wang, Qi Chen, Brandon Wormly, Brien Riley, F Anthony O'Neill, Dermot Walsh, Marylyn D Ritchie, Kenneth S Kendler, Xiangning Chen.   

Abstract

Schizophrenia is a common psychotic mental disorder that is believed to result from the effects of multiple genetic and environmental factors. In this study, we explored gene-gene interactions and main effects in both case-control (657 cases and 411 controls) and family-based (273 families, 1,350 subjects) datasets of English or Irish ancestry. Fifty three markers in 8 genes were genotyped in the family sample and 44 markers in 7 genes were genotyped in the case-control sample. The Multifactor Dimensionality Reduction Pedigree Disequilibrium Test (MDR-PDT) was used to examine epistasis in the family dataset and a 3-locus model was identified (permuted p=0.003). The 3-locus model involved the IL3 (rs2069803), RGS4 (rs2661319), and DTNBP1 (rs2619539) genes. We used MDR to analyze the case-control dataset containing the same markers typed in the RGS4, IL3 and DTNBP1 genes and found evidence of a joint effect between IL3 (rs31400) and DTNBP1 (rs760761) (cross-validation consistency 4/5, balanced prediction accuracy=56.84%, p=0.019). While this is not a direct replication, the results obtained from both the family and case-control samples collectively suggest that IL3 and DTNBP1 are likely to interact and jointly contribute to increase risk for schizophrenia. We also observed a significant main effect in DTNBP1, which survived correction for multiple comparisons, and numerous nominally significant effects in several genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804346      PMCID: PMC2746913          DOI: 10.1016/j.schres.2008.07.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  82 in total

1.  Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes.

Authors:  R E Straub; C J MacLean; Y Ma; B T Webb; M V Myakishev; C Harris-Kerr; B Wormley; H Sadek; B Kadambi; F A O'Neill; D Walsh; K S Kendler
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

3.  A note on exact tests of Hardy-Weinberg equilibrium.

Authors:  Janis E Wigginton; David J Cutler; Goncalo R Abecasis
Journal:  Am J Hum Genet       Date:  2005-03-23       Impact factor: 11.025

4.  Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia.

Authors:  Vincenzo De Luca; Subi Tharmalingam; Daniel J Müller; Greg Wong; Andrea de Bartolomeis; James L Kennedy
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

5.  Spurious genetic associations.

Authors:  Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-03-08       Impact factor: 13.382

6.  Modular epistasis in yeast metabolism.

Authors:  Daniel Segrè; Alexander Deluna; George M Church; Roy Kishony
Journal:  Nat Genet       Date:  2004-12-12       Impact factor: 38.330

7.  Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia.

Authors:  Xiangning Chen; Xu Wang; Shaon Hossain; F Anthony O'Neill; Dermot Walsh; Lora Pless; Kodavali V Chowdari; Vishwajit L Nimgaonkar; Sibylle G Schwab; Dieter B Wildenauer; Patrick F Sullivan; Edwin van den Oord; Kenneth S Kendler
Journal:  Hum Mol Genet       Date:  2006-10-09       Impact factor: 6.150

8.  Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families.

Authors:  K S Kendler; J M Myers; F A O'Neill; R Martin; B Murphy; C J MacLean; D Walsh; R E Straub
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

Review 9.  The molecular genetics of schizophrenia: new findings promise new insights.

Authors:  M J Owen; N M Williams; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2004-01       Impact factor: 15.992

10.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

View more
  10 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 2.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

3.  The effect of retrospective sampling on estimates of prediction error for multifactor dimensionality reduction.

Authors:  Stacey J Winham; Alison A Motsinger-Reif
Journal:  Ann Hum Genet       Date:  2011-01       Impact factor: 1.670

Review 4.  Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia.

Authors:  K M Prasad; M E Talkowski; K V Chowdari; L McClain; R H Yolken; V L Nimgaonkar
Journal:  Brain Res Bull       Date:  2009-09-01       Impact factor: 4.077

5.  A comparison of internal validation techniques for multifactor dimensionality reduction.

Authors:  Stacey J Winham; Andrew J Slater; Alison A Motsinger-Reif
Journal:  BMC Bioinformatics       Date:  2010-07-22       Impact factor: 3.169

Review 6.  Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.

Authors:  Cristina A Ghiani; Esteban C Dell'Angelica
Journal:  ASN Neuro       Date:  2011-05-27       Impact factor: 4.146

Review 7.  Methamphetamine-associated psychosis.

Authors:  Kathleen M Grant; Tricia D LeVan; Sandra M Wells; Ming Li; Scott F Stoltenberg; Howard E Gendelman; Gustavo Carlo; Rick A Bevins
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

8.  Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population.

Authors:  Feng-Ling Xu; Jun Yao; Xue Wu; Xi Xia; Jia-Xin Xing; Jin-Feng Xuan; Yong-Ping Liu; Bao-Jie Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-16       Impact factor: 2.570

9.  Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?

Authors:  Shaheen E Lakhan; Alon Kramer
Journal:  Behav Brain Funct       Date:  2009-01-07       Impact factor: 3.759

10.  The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors.

Authors:  Xiong-jian Luo; Ming Li; Liang Huang; Kwangsik Nho; Min Deng; Qiang Chen; Daniel R Weinberger; Alejandro Arias Vasquez; Mark Rijpkema; Venkata S Mattay; Andrew J Saykin; Li Shen; Guillén Fernández; Barbara Franke; Jing-chun Chen; Xiang-ning Chen; Jin-Kai Wang; Xiao Xiao; Xue-bin Qi; Kun Xiang; Ying-Mei Peng; Xiang-yu Cao; Yi Li; Xiao-dong Shi; Lin Gan; Bing Su
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.